10-76885239-T-TTA

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting

The NM_001161352.2(KCNMA1):​c.*2025_*2026dupTA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000418 in 480,628 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0010 ( 1 hom., cov: 30)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

KCNMA1
NM_001161352.2 3_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.715

Publications

0 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00103 (152/147468) while in subpopulation EAS AF = 0.0176 (90/5122). AF 95% confidence interval is 0.0146. There are 1 homozygotes in GnomAd4. There are 77 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNMA1NM_001161352.2 linkc.*2025_*2026dupTA 3_prime_UTR_variant Exon 28 of 28 ENST00000286628.14 NP_001154824.1 Q12791-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNMA1ENST00000286628.14 linkc.*2025_*2026dupTA 3_prime_UTR_variant Exon 28 of 28 1 NM_001161352.2 ENSP00000286628.8 Q12791-1

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
152
AN:
147468
Hom.:
1
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000679
Gnomad ASJ
AF:
0.00174
Gnomad EAS
AF:
0.0175
Gnomad SAS
AF:
0.000419
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000895
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000147
AC:
49
AN:
333160
Hom.:
0
Cov.:
5
AF XY:
0.000138
AC XY:
22
AN XY:
159154
show subpopulations
African (AFR)
AF:
0.000821
AC:
5
AN:
6090
American (AMR)
AF:
0.00
AC:
0
AN:
1008
Ashkenazi Jewish (ASJ)
AF:
0.00244
AC:
6
AN:
2464
East Asian (EAS)
AF:
0.0108
AC:
26
AN:
2406
South Asian (SAS)
AF:
0.00
AC:
0
AN:
6332
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
714
European-Non Finnish (NFE)
AF:
0.0000298
AC:
9
AN:
302294
Other (OTH)
AF:
0.000267
AC:
3
AN:
11250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
152
AN:
147468
Hom.:
1
Cov.:
30
AF XY:
0.00107
AC XY:
77
AN XY:
71860
show subpopulations
African (AFR)
AF:
0.00116
AC:
47
AN:
40632
American (AMR)
AF:
0.0000679
AC:
1
AN:
14738
Ashkenazi Jewish (ASJ)
AF:
0.00174
AC:
6
AN:
3444
East Asian (EAS)
AF:
0.0176
AC:
90
AN:
5122
South Asian (SAS)
AF:
0.000421
AC:
2
AN:
4746
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8506
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
276
European-Non Finnish (NFE)
AF:
0.0000895
AC:
6
AN:
67062
Other (OTH)
AF:
0.00
AC:
0
AN:
2034
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Generalized epilepsy-paroxysmal dyskinesia syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.71
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs562756117; hg19: chr10-78644997; COSMIC: COSV54265330; COSMIC: COSV54265330; API